Cite
MLA Citation
Michael A Davies et al.. “Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.” Lancet oncology, vol. 18, no. 7, n.d., pp. 863–873. http://access.bl.uk/ark:/81055/vdc_100046945315.0x000014